Stay updated with breaking news from Nasdaq Bcli. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI – Get Free Report) was the recipient of a significant growth in short interest during the month of November. As of November 15th, there was short interest totalling 3,770,000 shares, a growth of 5.6% from the October 31st total of 3,570,000 shares. Based on an average daily volume of 2,320,000 […]
StockNews.com began coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a research report report published on Sunday. The firm issued a hold rating on the biotechnology company’s stock. Separately, Maxim Group cut Brainstorm Cell Therapeutics from a buy rating to a hold rating in a research report on Thursday, September 28th. […]
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI – Get Free Report) saw a large decrease in short interest in October. As of October 31st, there was short interest totalling 3,570,000 shares, a decrease of 20.5% from the October 15th total of 4,490,000 shares. Approximately 9.8% of the company’s stock are short sold. Based on an average daily […]
StockNews.com assumed coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a research report sent to investors on Thursday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, Maxim Group cut Brainstorm Cell Therapeutics from a buy rating to a hold rating in a research report on Thursday, […]
StockNews.com assumed coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Get Free Report) in a research report issued on Tuesday. The brokerage set a “hold” rating on the biotechnology company’s stock. Separately, Maxim Group downgraded Brainstorm Cell Therapeutics from a “buy” rating to a “hold” rating in a research report on Thursday, September 28th. […]